- Min.Order :0 Metric Ton
- Purity: 98%
- Payment Terms : T/T,,MoneyGram
Keywords
GTS-21 treatment of Alzheimer's disease treat of nicotine dependence and schizophrenia
Quick Details
- Appearance:
- Application:being investigated for the treatment of Alzheimer's disease,nicotine dependence, and, most significantly, for schizophrenia.
- PackAge:
- ProductionCapacity:|Metric Ton|Day
- Storage:
- Transportation:
Details:
"In conclusion, GTS-21 was well tolerated up to doses of 450 mg/day (150 mg t.i.d.) and shows improvements in cognitive behavior in normal subjects. The pharmacokinetics appear to be linear over the range of dose
studies and the variability, primarily intersubject, decrease with con- tinued dosing. The data provide important evidence that GTS-21 has the potential to improve human cognitive function. The range of the
effects is important, clear benefits being seen to three major cognitive functions (attention, working memory, episodic secondary memory). In addi- tion, there appears to be a relationship between the duration and
magnitude of exposure to GTS-21 and/or 4-OH-GTS-21 and the magnitude of effect, with doses between 75 and 150 mg t.i.d. approaching maximal effect. GTS-21 may represent a novel treatment for dementia, and should
be investigated further for its potential therapeutic effects in a variety of conditions in which cognitive function is compromised, not least of all Alzheimer’s disease."
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View